Hims & Hers Q3 2026 Earnings Report

Hims & Hers reports 49% revenue growth with international expansion accelerating.

16 cards · 1m 40s · tap to begin

From · · · 1m 40s

Hims & Hers Q3 2026 Earnings Report

Hims & Hers reports 49% revenue growth with international expansion accelerating.

In brief

Hims & Hers reports 49% revenue growth with international expansion accelerating. Hims & Hers Health achieved $890.4 million Q3 revenue, 2.788 million subscribers, and a 9% adjusted EBITDA margin while expanding international markets. Originally reported by The Motley Fool.

Q3 Revenue Growth

Hims & Hers (HIMS) Q3 2026 Earnings Call Transcript

Revenue grew 49% year over year to $890.4 million.

Subscribers

2.788 million subscribers, 13% year over year growth.

International Expansion

Rest of world revenue grew 321% year over year following Eucalyptus acquisition.

Adjusted EBITDA

Adjusted EBITDA of $82.4 million, 9% margin.

Net Loss

Net loss of $33.0 million compared to net income of $15.8 million in prior year.

Marketing Efficiency

Marketing efficiency improved 7 percentage points to 28% of revenue.

Technology Investment

Technology and platform investment at 8% of revenue, largest engineering hiring quarter.

Testosterone Offering

Testosterone specialty revenue approaching $100 million annualized run rate.

Peptides+ Launch

Peptides+ offering launching late November 2026 with clinician-led treatment plans.

Hers 2.0 App

Hers 2.0 app launched with integrated AI care coaching and expanded engagement tools.

International Brands

Hers launched in Australia and Germany; Hims launched in Germany and Australia.

AI Native Experience

AI native experience now available to large majority of weight loss customers.

Weight Loss Partnerships

Agreement with Eli Lilly to expand access to Foundayo and Zepbound.

Fourth Quarter Guidance

Q4 revenue guidance of $875 million to $895 million.

Full Year 2026 Guidance

Full year 2026 revenue guidance of $3.13 billion to $3.15 billion.

Subscribers Decline

Net subscriber decrease of 100,000 due to measured marketing spend.

At a glance

Hims & Hers Health achieved $890.4 million Q3 revenue, 2.788 million subscribers, and a 9% adjusted EBITDA margin while expanding international markets.

Read the original on The Motley Fool

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on hims and related topics.